Home / CDMO Services / CDMO研发 / CDMO研发 detail
Leveraging the technical advantages in Structure-Based Drug Discovery (SBDD), Viva provides leading CRO drug discovery services and CMC/CDMO services throughout the whole drug production process to global biopharmaceutical clients. Zhejiang Langhua Pharmaceutical Co., Ltd, a Viva Biotech Holdings subsidiary, is a comprehensive pharmaceutical company engaged in drug research, development, and production. Langhua helps offer our worldwide partners a one-stop CDMO solution in new drugs' entire life cycle for small molecule Active Pharmaceutical Ingredients (API) and Finished Dosage Form (FDF), from pre-clinical to commercial supply.
With the advanced technology platform, US-FDA/NMPA/EDQM/PMDA/WHO/ANVISA approved manufacturing site, and robust EHS system, we contributed to more than 20 new drug launches in the past years and ensured long-term and sustainable supply of our outstanding services and products to our global partners. We are committed to being the most innovative, reliable CDMO service provider in the world, contributing to new medicine's availability, affordability, and quick access to the public.
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号
- About Us
-
CRO Services
BackCRO ServicesDiscovery Biology Services
- CDMO Services
- EFS Business
- News
- Careers
- Investor Relations
- Contact Us